Cytokine Therapies and Inhibitors: A Vibrant Pipeline and Active Approved Market 

Mark C. Via

Table 1.1. Overview of the Interleukins
Table 1.2. CC, C, CXC, and CX3C Chemokine/Receptor Families
Table 2.1. Interleukin Therapeutics That Are Approved or in Clinical Trials
Table 2.2. Interferon Therapeutics That Are Approved or in Clinical Trials
Table 2.3. TNF Therapeutics in Clinical Trials
Table 2.4. Hematopoietic Growth Factor Therapeutics That Are Approved or in Clinical Trials
Table 3.1. Interleukin Inhibitors That Are Approved or in Clinical Trials
Table 3.2. Interferon Inhibitors in Clinical Trials
Table 3.3. TNF Inhibitors That Are Approved or in Clinical Trials
Table 3.4. TGF-? Inhibitors in Clinical Trials
Table 3.5. Chemokine Antagonists in Clinical Trials
Table 4.1. Sales of Selected Cytokine-Based Drugs, 2004 and 2005
Table 4.2. Estimated New Cancer Cases in the United States, Total and Selected Types, 2006